We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$242B
AUM Growth
+$21.5B
Cap. Flow
-$6.23B
Cap. Flow %
-2.57%
Top 10 Hldgs %
14.62%
Holding
8,700
New
579
Increased
2,998
Reduced
3,843
Closed
903

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$716M
2
AMZN icon
Amazon
AMZN
+$685M
3
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$508M
4
JPM icon
JPMorgan Chase
JPM
+$403M
5
COST icon
Costco
COST
+$347M

Sector Composition

Rank Sector Weight
1 Technology 9.65%
2 Financials 6.89%
3 Healthcare 6.2%
4 Consumer Discretionary 5.88%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YARW
6526
Yarrow Bioscience, Inc. Common Stock
YARW
$25.4M
$15K ﹤0.01%
1
-1
-50% -$24K
WBIG icon
6527
WBI BullBear Yield 3000 ETF
WBIG
$31.6M
$15K ﹤0.01%
613
-1,887
-75% -$45.2K
XTLB
6528
XTL Biopharmaceuticals
XTLB
$7.03M
$15K ﹤0.01%
1,582
-86
-5% -$778
CTHR
6529
DELISTED
Charles & Colvard Ltd
CTHR
$15K ﹤0.01%
1,373
-885
-39% -$8.77K
FRTX
6530
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$15K ﹤0.01%
39
+37
+1,850% +$12.4K
FRGI
6531
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$15K ﹤0.01%
1,146
-8,817
-88% -$130K
SEAC
6532
DELISTED
Seachange International Inc
SEAC
$15K ﹤0.01%
+548
New +$17K
AHPI
6533
DELISTED
Allied Healthcare Products
AHPI
$15K ﹤0.01%
8,388
+6,957
+486% +$13K
SECO
6534
DELISTED
Secoo Holding Limited ADR
SECO
$15K ﹤0.01%
167
-82
-33% -$7.29K
SYNC
6535
DELISTED
Synacor, Inc.
SYNC
$15K ﹤0.01%
10,075
+3,470
+53% +$6.06K
DZSI
6536
DELISTED
DZS Inc. Common Stock
DZSI
$15K ﹤0.01%
1,400
-2,161
-61% -$27.3K
SCIX
6537
DELISTED
Global X Scientific Beta Asia ex-Japan ETF
SCIX
$15K ﹤0.01%
600
DNR
6538
DELISTED
Denbury Resources, Inc.
DNR
$15K ﹤0.01%
7,537
-7,846
-51% -$15.6K
AVX
6539
DELISTED
AVX Corporation
AVX
$15K ﹤0.01%
897
-16,999
-95% -$297K
ORG
6540
DELISTED
The Organics ETF
ORG
$15K ﹤0.01%
+558
New +$14.7K
MPVD
6541
DELISTED
Mountain Province Diamonds Inc.
MPVD
$15K ﹤0.01%
+17,143
New +$18.9K
GNMX
6542
DELISTED
Aevi Genomic Medicine Inc
GNMX
$15K ﹤0.01%
77,032
+72,032
+1,441% +$16K
SDT
6543
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$15K ﹤0.01%
15,230
+1,449
+11% +$1.44K
TRNX
6544
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$15K ﹤0.01%
4,607
+4,526
+5,588% +$47.8K
GNCA
6545
DELISTED
Genocea Biosciences, Inc.
GNCA
$15K ﹤0.01%
3,101
-238
-7% -$1.18K
GNRX
6546
DELISTED
VanEck Vectors Generic Drugs ETF
GNRX
$15K ﹤0.01%
+660
New +$14.5K
BDCS
6547
DELISTED
UBS AG Exchange Traded Access Securities (E-TRACS)Linked to the Wells Fargo Business Development Com
BDCS
$15K ﹤0.01%
+771
New +$14.9K
SORL
6548
DELISTED
SORL Auto Parts, Inc.
SORL
$15K ﹤0.01%
5,097
-1,726
-25% -$5.02K
ABIL
6549
DELISTED
Ability Inc
ABIL
$15K ﹤0.01%
8,981
+1,659
+23% +$3.23K
AGF
6550
DELISTED
DB Agriculture Long ETN due April 1, 2038
AGF
$15K ﹤0.01%
1,855

Similar funds

UBS Group's Q1 2019 Portfolio in Review

As of Q1 2019, UBS Group held 8,700 positions worth $242B, up 9.8% from $221B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q1 2019 filing shows 579 new, 2,998 increased, 3,843 reduced and 903 closed positions. Its largest new stake was PIMCO Dynamic Income Strategy Fund: 753,726 shares worth $15.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.53B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q1 2019 buy was PIMCO Dynamic Income Strategy Fund: 753,726 shares worth $15.4M.
  • UBS Group added most to Microsoft in Q1 2019, an estimated $716M increase.
  • UBS Group's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.53B.
  • UBS Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $341M.
  • UBS Group's ten largest holdings make up 15% of its $242B portfolio in Q1 2019.
  • UBS Group opened 579 new positions and closed 903 in Q1 2019.
  • UBS Group's portfolio value rose 9.8% quarter-over-quarter to $242B.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.